Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

During the Trading Day
10.07 -0.51 / -4.82%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.07 0.00 / 0.00%
Volume: 889.00

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 15.00. The median estimate represents a +173.09% increase from the last price of 10.07.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.40%
Growthannually 5.27%


Growthquarterly 96.20%
Growthannually 76.52%
Key to the earnings and sales forecast charts.